New test available:
mHam 2.0 – Complement-Dependent Cell Killing Assay
access results
contact us
1 800 566 3462
Cro Inquiries
Test Information
Search for Tests
Reference Laboratory Services
By Specialty Area
Order Forms
Clinical Match Policy
Specimen Collection & Shipping
Machaon Live
Clinical Trial Services
Rare Disease CRO
Central Laboratory Services
Subject, Site & Sample Finder
Innovative Trial Solutions
FAQ
Client Support Center
Access Results
Billing and Payments
Secure Messaging
Courier Management
Job Aids
FAQ
Education
Podcasts
By Specialty Area
About Us
About Us
Our Leadership
Lab Licenses
Test Requisitions & Forms
Operational Policies
Careers
Testimonials
Test Information
Search for Tests
Reference Laboratory Services
Coagulation & Platelets Testing
Complement Testing
Advanced Genetic Testing
Sponsored Testing Programs
By Specialty Area
Coagulation
Genetics
Complement
Rare Disease
Immunology
Platelet
Order Forms
Clinical Match Policy
Specimen Collection & Shipping
Machaon Live
Clinical Trial Services
Rare Disease CRO
Central Laboratory Services
Subject, Site & Sample Finder
Innovative Trial Solutions
FAQ
Client Support Center
Access Results
Billing and Payments
Secure Messaging
Courier Management
Job Aids
FAQ
Education
Podcasts
By Specialty Area
Coagulation
Genetics
Complement
Rare Disease
Immunology
Platelet
About Us
About Us
Our Leadership
Lab Licenses
Test Requisitions & Forms
Operational Policies
Careers
Testimonials
access results
contact us
1 800 566 3462
Cro Inquiries
Heparin Antibody Panel
Kevin Fritsch
on
February 8, 2023
Hypercoagulability Panel
Kevin Fritsch
on
February 8, 2023
LA Coag Antiphospholipid Antibody Panel
Kevin Fritsch
on
February 8, 2023
Lupus Anticoagulant Screen
Kevin Fritsch
on
February 8, 2023
Lupus Anticoagulant Panel
Kevin Fritsch
on
February 8, 2023
Dysfibrinogenemia Functional Panel
Kevin Fritsch
on
February 8, 2023
Mild Bleeding Work-up
Kevin Fritsch
on
February 8, 2023
Prolonged aPTT/PT Evaluation Work-up
Kevin Fritsch
on
February 8, 2023
Protein C Activity
Kevin Fritsch
on
February 8, 2023
von Willebrand Factor Multimer
Kevin Fritsch
on
February 8, 2023
Posts navigation
Previous
1
2
3
4
…
8
Next